论文部分内容阅读
应用丽珠赛乐（国产脑活素）对30例新生地缺氧缺血性脑病（HIE）疗效进行观察，并与同期国外脑活素治疗30例进行对比，两组基本情况经统计学处理，P均＞0．05。治疗后NBNA评分＜35分各为28％、25％，颅脑B超异常率各为33．3％及3o％，P均＞0．05。随访结果：后遗症发生率各为14．2％及11．l％，病死率分别为3．6％、7．4％，P均＞0．05。丽珠赛乐与脑活素治疗HIE的疗效无明显差异。
30 cases of neonatal hypoxic-ischemic encephalopathy (HIE) were observed with CZL (Chinese-made cerebrolysin) and compared with 30 cases treated with cerebrolysin at the same period. The basic conditions of the two groups were statistically analyzed , P> 0.05. After treatment, the score of NBNA <35 was 28% and 25% respectively, and the abnormal rate of brain B ultrasonic was 33.3% and 3% respectively, all P> 0.05. Follow-up results: The incidence of sequelae was 14.2% and 11 respectively. l%, the case fatality rate was 3.6%, 7.4%, P> 0.05. No significant difference was found between the efficacy of CZL and cerebrolysin in the treatment of HIE.